Philogen revenue and financials
In the fiscal year ended December 2025, Philogen reported revenue of €319.73M (+313.81% year over year). Net income was €229.68M, a net margin of 71.8%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +313.81%
- 2025 vs 2024
- Net income growth
- +407.10%
- 2025 vs 2024
- Net margin
- 71.8%
- 2024: 58.6%
How Philogen is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 119.0% a year on average over the last 5 years
Compound annual growth rate: from €6.35M in 2020 to €319.73M in 2025.
Operating margin rose from −0.5% to 80.4%
Operating income over revenue, 2022 → 2025: 80.9 percentage points.
Profits turn into cash: free cash flow equal to 109% of net income
Totals for fiscal years 2023–2025: free cash flow €292.88M, net income €268.81M.
Shares outstanding up 13.3% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 320 | 77.3 | 24.7 | 26.9 | 5.0 | 6.3 | 15.1 | 15.7 | 13.8 | 10.1 |
| Cost of revenue | 39.6 | 19.6 | 17.5 | 13.2 | 10.6 | 9.8 | 8.3 | 6.2 | 5.4 | 5.2 |
| Gross profit | 280 | 57.7 | 7.3 | 13.8 | -5.7 | -3.5 | 6.7 | 9.5 | 8.4 | 4.9 |
| Selling, general and administrative | 18.5 | 16.0 | 12.5 | 10.7 | 9.1 | 7.0 | 6.9 | 5.8 | 5.5 | 2.8 |
| Research and development | 3.4 | 2.2 | 3.5 | 1.9 | — | — | — | — | — | — |
| Operating income | 257 | 37.3 | -9.3 | -0.1 | -16.8 | -12.1 | -1.9 | 2.3 | 1.7 | 1.1 |
| EBIT | 257 | 37.3 | -9.3 | -0.1 | -16.8 | -12.1 | -1.9 | 2.3 | 1.7 | 1.1 |
| EBITDA | 260 | 40.2 | -6.6 | 1.7 | -15.7 | -11.4 | -1.2 | 3.4 | 2.7 | 1.7 |
| Interest expense | 0.3 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 1.9 | 1.1 | 0.1 |
| Pre-tax income | 260 | 40.4 | -6.2 | -4.4 | -15.2 | -12.4 | 2.4 | 1.6 | 3.5 | -0.6 |
| Income tax | 30.4 | -4.9 | -0.0 | 1.0 | 0.5 | 0.9 | 1.0 | -2.1 | 1.0 | -0.3 |
| Net income | 230 | 45.3 | -6.2 | -5.4 | -15.7 | -13.3 | 1.4 | 3.7 | 2.5 | -0.2 |
| Net income to common shareholders | 230 | 45.3 | -6.2 | -5.4 | -15.7 | -13.3 | 1.4 | 3.7 | 2.5 | -0.2 |
| Basic EPS | 5.70 | 1.12 | -0.15 | -0.13 | -0.40 | -0.37 | 0.04 | 0.09 | 0.06 | -0.01 |
| Diluted EPS | 5.70 | 1.12 | -0.15 | -0.13 | -0.40 | -0.37 | 0.04 | 0.09 | 0.06 | -0.01 |
| Average shares (basic) | 40.3 | 40.3 | 40.2 | 40.6 | 39.6 | 35.6 | 38.4 | 41.1 | 41.7 | 37.5 |
| Average shares (diluted) | 40.3 | 40.3 | 40.2 | 40.6 | 39.8 | 35.6 | 40.0 | 41.1 | 41.7 | 37.5 |
| Dividend per share | 0.70 | — | — | — | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.1 | 311 | 8.5 | 75.7 | 1.5 | 2.4 | 22.3 | 6.9 | 20.0 | 3.0 |
| Cost of revenue | 14.9 | 25.5 | 14.1 | 10.5 | 9.0 | 9.9 | 7.6 | 7.5 | 5.7 | 5.3 |
| Gross profit | -10.9 | 286 | -5.6 | 65.2 | -7.5 | -7.5 | 14.8 | -0.6 | 14.3 | -2.3 |
| Selling, general and administrative | 10.2 | 10.1 | 8.4 | 8.3 | 7.7 | 6.4 | 6.1 | 5.5 | 5.2 | 4.4 |
| Operating income | -23.5 | 273 | -16.0 | 54.6 | -17.3 | -16.0 | 6.7 | -7.8 | 7.7 | -7.9 |
| EBIT | -23.5 | 273 | -16.0 | 54.6 | -17.3 | -16.0 | 6.7 | -7.8 | 7.7 | -7.9 |
| EBITDA | -21.9 | 275 | -14.6 | 56.1 | -16.0 | -14.6 | 8.0 | -6.8 | 8.5 | -7.2 |
| Interest expense | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 |
| Pre-tax income | -20.5 | 275 | -15.4 | 55.9 | -15.5 | -14.4 | 8.3 | -7.8 | 3.4 | -7.0 |
| Income tax | -0.9 | 30.9 | -0.5 | -4.9 | 0.0 | -0.6 | 0.6 | -0.4 | 1.5 | 0.1 |
| Net income | -19.6 | 245 | -14.9 | 60.8 | -15.5 | -13.8 | 7.7 | -7.4 | 2.0 | -7.1 |
| Net income to common shareholders | -19.6 | 245 | -14.9 | 60.8 | -15.5 | -13.8 | 7.7 | -7.4 | 2.0 | -7.1 |
| Basic EPS | -0.49 | 6.04 | -0.37 | 1.51 | -0.39 | -0.34 | 0.19 | -0.18 | 0.05 | -0.18 |
| Diluted EPS | -0.49 | 6.04 | -0.37 | 1.51 | -0.39 | -0.34 | 0.19 | -0.18 | 0.05 | -0.18 |
| Average shares (basic) | 40.3 | 40.5 | 40.1 | 40.3 | 40.3 | 40.1 | 40.4 | 40.6 | 40.6 | 39.6 |
| Average shares (diluted) | 40.3 | 40.5 | 40.1 | 40.3 | 40.3 | 40.1 | 40.4 | 40.6 | 40.6 | 40.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 437 | 168 | 119 | 126 | 133 | 85.5 | 96.3 | 69.5 | 59.2 | 29.7 |
| Current assets | 398 | 132 | 89.2 | 99.0 | 108 | 67.9 | 80.0 | 50.9 | 42.9 | 14.9 |
| Cash and equivalents | 127 | 30.6 | 15.6 | 24.4 | 8.9 | 12.0 | 3.6 | 6.4 | 6.5 | 2.4 |
| Short-term investments | 149 | 54.7 | 28.6 | 22.9 | 0.5 | 50.0 | 71.0 | 30.7 | 28.1 | 6.4 |
| Receivables | 15.4 | 15.0 | 11.4 | 10.6 | 5.3 | 5.1 | 4.1 | 12.3 | 5.6 | 5.7 |
| Inventory | 3.0 | 3.3 | 2.2 | 1.9 | 1.3 | 0.8 | 0.6 | 0.5 | 0.6 | 0.5 |
| Net property, plant and equipment | 24.8 | 24.9 | 25.9 | 22.6 | 21.0 | 15.5 | 13.2 | 12.5 | 12.6 | 12.2 |
| Other intangible assets | 1.1 | 1.2 | 1.2 | 1.2 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.2 |
| Current liabilities | 51.3 | 16.6 | 12.7 | 10.8 | 11.6 | 12.8 | 13.7 | 22.6 | 14.3 | 18.6 |
| Accounts payable | 13.0 | 9.6 | 7.8 | 6.4 | 5.8 | 3.9 | 3.3 | 2.1 | 2.2 | 2.5 |
| Long-term debt | — | — | 1.9 | 3.0 | 3.6 | 4.6 | 0.7 | 5.6 | 6.4 | 2.8 |
| Total debt | 10.9 | 11.5 | 14.9 | 15.8 | 16.5 | 17.7 | 13.8 | 6.5 | 7.2 | 2.9 |
| Total liabilities | 63.5 | 29.8 | 28.7 | 27.9 | 27.7 | 29.8 | 27.5 | 29.2 | 21.8 | 22.1 |
| Total equity (incl. minority) | 374 | 139 | 90.6 | 97.9 | 105 | 55.7 | 68.8 | 40.3 | 37.4 | 7.6 |
| Retained earnings | 268 | 38.6 | -11.5 | -11.7 | -20.0 | -4.3 | 8.9 | 17.6 | 14.9 | 2.8 |
| Minority interest | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 396 | 437 | 159 | 168 | 105 | 119 | 135 | 126 | 137 | 133 |
| Current assets | 355 | 398 | 119 | 132 | 75.3 | 89.2 | 107 | 99.0 | 113 | 108 |
| Cash and equivalents | 5.1 | 127 | 11.2 | 30.6 | 12.3 | 15.6 | 36.6 | 24.4 | 11.5 | 8.9 |
| Short-term investments | 219 | 149 | 88.8 | 54.7 | 24.1 | 28.6 | 57.7 | 22.9 | 86.9 | 0.5 |
| Receivables | 14.3 | 15.4 | 14.0 | 15.0 | 7.3 | 11.4 | 9.7 | 10.6 | 12.0 | 5.3 |
| Inventory | 2.9 | 3.0 | 4.3 | 3.3 | 2.9 | 2.2 | 2.5 | 1.9 | 1.9 | 1.3 |
| Net property, plant and equipment | 24.3 | 24.8 | 25.2 | 24.9 | 25.5 | 25.9 | 23.0 | 22.6 | 22.8 | 21.0 |
| Other intangible assets | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | 1.2 | 1.1 | 1.0 |
| Current liabilities | 50.8 | 51.3 | 20.8 | 16.6 | 14.4 | 12.7 | 13.7 | 10.8 | 15.4 | 11.6 |
| Accounts payable | 11.6 | 13.0 | 13.5 | 9.6 | 8.9 | 7.8 | 8.0 | 6.4 | 6.4 | 5.8 |
| Long-term debt | — | — | — | — | 1.5 | 1.9 | 2.4 | 3.0 | 3.3 | 3.6 |
| Total debt | 11.4 | 10.9 | 11.5 | 11.5 | 13.9 | 14.9 | 15.2 | 15.8 | 16.2 | 16.5 |
| Total liabilities | 63.8 | 63.5 | 33.5 | 29.8 | 28.9 | 28.7 | 30.1 | 27.9 | 31.2 | 27.7 |
| Total equity (incl. minority) | 332 | 374 | 126 | 139 | 75.8 | 90.6 | 105 | 97.9 | 106 | 105 |
| Retained earnings | -21.6 | 268 | -14.9 | 38.6 | -20.9 | -11.5 | 2.3 | -11.7 | -4.4 | -20.0 |
| Minority interest | — | 0.0 | — | — | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 268 | 40.8 | -4.8 | -4.9 | -19.0 | -13.2 | 7.5 | 5.4 | -6.8 | 6.7 |
| Depreciation and amortization | 4.3 | 3.9 | 3.6 | 2.8 | 1.9 | 1.5 | 1.1 | 1.1 | 1.0 | 0.6 |
| Capital expenditure | -3.4 | -2.2 | -5.5 | -3.9 | -6.6 | -3.5 | -1.2 | -0.6 | -0.4 | -4.7 |
| Investing cash flow | -168 | -22.3 | 0.2 | 24.2 | -47.8 | 17.8 | -32.5 | -3.6 | 17.8 | -4.7 |
| Financing cash flow | -3.0 | -3.8 | -4.2 | -3.8 | 63.1 | 3.8 | 29.1 | -1.9 | -6.8 | -1.3 |
| Dividends paid | — | — | — | — | — | — | -21.9 | -1.0 | -1.0 | — |
| Share repurchases | -1.8 | -0.0 | -2.4 | -1.9 | -0.5 | — | — | — | — | — |
| Debt issued | 0.0 | 0.0 | 0.0 | 0.0 | — | 5.0 | — | — | 1.9 | 2.7 |
| Debt repaid | -1.2 | -3.8 | -1.8 | -1.9 | -1.8 | -1.2 | -11.0 | -0.9 | -7.6 | -0.1 |
| Effect of exchange rates | 0.7 | 0.2 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | -0.0 | — |
| Net change in cash | 96.6 | 14.9 | -8.8 | 15.6 | -3.1 | 8.4 | -2.8 | -0.1 | 4.2 | 0.7 |
| Free cash flow | 265 | 38.7 | -10.4 | -8.8 | -25.6 | — | — | — | — | — |
| Levered free cash flow | 202 | 27.4 | -7.3 | -8.4 | -17.7 | -12.0 | 7.4 | 3.4 | — | 4.5 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -14.8 | 279 | -11.3 | 50.9 | -10.0 | -15.1 | 10.3 | -10.9 | 6.0 | -8.3 |
| Depreciation and amortization | 2.2 | 2.3 | 2.0 | 2.1 | 1.8 | 1.9 | 1.7 | 1.5 | 1.2 | 1.1 |
| Capital expenditure | -0.3 | -1.7 | -1.7 | -0.7 | -1.4 | -4.0 | -1.5 | -0.6 | -3.3 | -2.7 |
| Investing cash flow | -77.5 | -162 | -6.2 | -29.9 | 7.6 | -3.8 | 3.9 | 25.0 | -0.8 | -2.9 |
| Financing cash flow | -29.7 | -1.1 | -1.9 | -2.9 | -0.9 | -2.1 | -2.1 | -1.2 | -2.6 | -1.6 |
| Dividends paid | -28.2 | — | — | — | — | — | — | — | — | — |
| Share repurchases | -0.7 | -0.5 | -1.4 | -0.0 | — | -1.2 | -1.2 | -0.3 | -1.6 | -4.2 |
| Debt repaid | -0.8 | -0.6 | -0.6 | -2.9 | -0.9 | -0.9 | -0.9 | -0.8 | -1.0 | -1.0 |
| Effect of exchange rates | 1.8 | 0.7 | 0.0 | 0.2 | -0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 |
| Net change in cash | -122 | 116 | -19.4 | 18.3 | -3.4 | -21.0 | 12.2 | 13.0 | 2.6 | -12.6 |
| Free cash flow | -15.2 | 278 | -13.0 | 50.1 | -11.5 | -19.2 | 8.8 | -11.5 | 2.7 | -11.1 |
| Levered free cash flow | -8.9 | 205 | -3.0 | 32.2 | -4.8 | -14.4 | 7.1 | -7.3 | -1.1 | 82.5 |
Financial statements of similar companies
Companies in the group: same industry, similar size
